Kenji Nozaki

4PUBLICATIONS
2CO-AUTHORS
Predictive and prognostic markersTumour immunologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 13, 2021
Pretreatment levels of serum soluble interleukin-2 receptor are useful in selecting the treatment regimen for newly diagnosed advanced-stage follicular lymphoma with low tumor burden.

Kenji Nozaki, Hiroyuki Sugahara, Shuji Ueda

|Feb 09, 2021
Flow cytometry analysis of peripheral Tregs in patients with multiple myeloma under lenalidomide maintenance.

Kenji Nozaki, Yuki Fujioka, Daisuke Sugiyama

|Nov 25, 2020
Whole-exome sequencing identified mutational profile of a case with T-cell chronic lymphocytic leukemia.

Kenji Nozaki, Takafumi Yokota, Eri Itotagawa

|Oct 24, 2020
The role of local radiotherapy following rituximab-containing chemotherapy in patients with transformed indolent B-cell lymphoma.

Kenji Nozaki, Dai Maruyama, Akiko Miyagi Maeshima

Pageof 1

Frequent Collaborators

1 joint publications

Dai Maruyama

1 joint publications

Kosuke Toyoda